bluebird bio Inc - Company Profile
Powered by 
All the data and insights you need on bluebird bio Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date bluebird bio Inc Strategy Report
- Understand bluebird bio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on bluebird bio Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into bluebird bio Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Andrew Obenshain
President; Chief Executive Officer; Director Executive BoardMr. Andrew Obenshain has been the Chief Executive Officer and Director of the company since 2021. Prior to this, he served as the President of Severe Genetic Diseases since 2020 and Senior Vice President of Head of Europe since 2016. Before that, he served as the General Manager of France and Benelux overseeing a portfolio including seven rare disease products at Shire in Paris.
Christopher Krawtschuk
Chief Financial Officer Senior ManagementMr. Chris Krawtschuk has been the chief financial officer in November 2022. Prior to this, he served as the Chief Financial Officer of Jubilant Pharma. He also served as VP, Lead Divisional Controller for Pfizer Inc.
Thomas J. Klima
Chief Operating Officer; Chief Commercial Officer Senior ManagementMr. Tom Klima has been the Chief Commercial Officer and Chief Operating Officer of the company since 2021. Prior to this, he served as the Chief Commercial Officer at Gamida Cell. Before that, he served in several leadership roles at Atara Biotherapeutics, Navidea Biopharmaceuticals and Algeta U.S. Prior joining to Algeta, he served in several commercial leadership positions at Dendreon.
Richard A. Colvin, M.D., Ph.D.
Chief Medical Officer Senior ManagementDr. Rich Colvin has been the Chief Medical Officer of the company since 2021. Prior to this, he served as the Executive Director in Translational Medicine at Novartis.
Joseph Vittiglio
Chief Business and Legal Officer Senior ManagementMr. Joseph Vittiglio has been the Chief Business and Legal Officer of the company since January 2023. Prior to this he served as a Chief Business and Legal Officer at Finch Therapeutics, General Counsel and Chief Business Officer for AMAG Pharmaceuticals Inc
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer